Management of Dermatologic Toxicities Associated with Targeted Therapies
This information was originally presented at the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.
This activity is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Identify and recommend treatment for skin toxicities associated with targeted therapies for cancer
Mario E. Lacouture, MD
Memorial Sloan Kettering Cancer Center
- 1.25 Participation
- 1.17 Nurse
- 1.25 Pharmacist
- 1.25 Physician